Amylin Pharmaceuticals to Present at Deutsche Bank 37th Annual Health Care Conference
April 30 2012 - 4:21PM
Business Wire
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting
at the Deutsche Bank 37th Annual Health Care Conference on Monday,
May 7, 2012 at 2:10 p.m. ET / 11:10 a.m. PT in Boston. Daniel M.
Bradbury, president and chief executive officer of Amylin
Pharmaceuticals, will provide a corporate overview.
The presentation will be webcast through the “Investors” section
of Amylin’s corporate website at www.amylin.com, and a recording
will be made available following the event. To access the live
webcast, please log on to Amylin's site approximately fifteen
minutes prior to the presentation to register and download any
necessary audio software.
About Amylin PharmaceuticalsAmylin Pharmaceuticals is a
biopharmaceutical company dedicated to improving lives of patients
through the discovery, development and commercialization of
innovative medicines. Amylin is committed to delivering novel
therapies that transform the way diabetes and other metabolic
disorders are treated. Amylin is headquartered in San Diego,
Calif., and has a commercial manufacturing facility in Ohio. More
information on Amylin Pharmaceuticals is available at
www.amylin.com.
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024